renal function and antihypertensive drug efficacy were determined in a prospective , double-blind , multicenter study comparing enalapril plus hydrochlorothiazide with standard triple therapy ( hydrochlorothiazide , timolol , and hydralazine ) in 75 patients with documented renovascular hypertension .
C0717738
enalapril
C0020261
hydrochlorothiazide